Shanghai - Delayed Quote CNY

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (605016.SS)

26.31 +0.31 (+1.19%)
At close: April 26 at 3:00 PM GMT+8
Key Events
Loading Chart for 605016.SS
DELL
  • Previous Close 26.00
  • Open 26.06
  • Bid 26.29 x --
  • Ask 26.31 x --
  • Day's Range 25.61 - 26.46
  • 52 Week Range 19.37 - 30.49
  • Volume 686,664
  • Avg. Volume 1,121,233
  • Market Cap (intraday) 6.539B
  • Beta (5Y Monthly) 0.43
  • PE Ratio (TTM) 50.60
  • EPS (TTM) 0.52
  • Earnings Date --
  • Forward Dividend & Yield 0.17 (0.65%)
  • Ex-Dividend Date Jun 1, 2023
  • 1y Target Est 26.70

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. engages in the production and sale of functional sugar in China and internationally. The company offers dietary fibers, including polydextrose and resistant dextrin; prebiotics, such as fructo-oligosaccharide, isomalto- oligosaccharide, galacto- oligosaccharide, and xylo- oligosaccharide. It also provides starch sugars comprising allulose, maltitol, organic maltodextrin, allulose psicose, and isomaltulose, as well as allulose power and maltitol syrups. The company's products are used in food, medicine, health, and diary related products. It serves in the markets, including Africa, Asia, Europe, Australia, and the Americas. Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. was founded in 2005 and is based in Yucheng, China.

www.sdblcy.com

--

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: 605016.SS

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

605016.SS
7.33%
SSE Composite Index
3.82%

1-Year Return

605016.SS
39.91%
SSE Composite Index
5.40%

3-Year Return

605016.SS
104.60%
SSE Composite Index
11.10%

5-Year Return

605016.SS
--
SSE Composite Index
11.07%

Compare To: 605016.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 605016.SS

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    6.54B

  • Enterprise Value

    6.10B

  • Trailing P/E

    50.88

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    9.57

  • Price/Book (mrq)

    4.49

  • Enterprise Value/Revenue

    7.39

  • Enterprise Value/EBITDA

    29.67

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    22.23%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    13.78%

  • Revenue (ttm)

    868.26M

  • Net Income Avi to Common (ttm)

    192.99M

  • Diluted EPS (ttm)

    0.52

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    493.78M

  • Total Debt/Equity (mrq)

    3.60%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 605016.SS

Analyst Price Targets

20.40 Low
26.70 Average
26.31 Current
33.00 High
 

Fair Value

 

Company Insights: 605016.SS